Where to find our staff next week
At ACR 2016, you’ll find Cleveland Clinic physicians and fellows from the Department of Rheumatic and Immunologic Diseases everywhere from oral sessions to workshops and ‘Meet the Professor’ activities. Don’t miss these 8 oral and poster presentations on topics from rare vasculitides to checkpoint therapy; for a full listing, download our guide to ACR 2016.
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Sunday, Nov. 13
A Randomized Double-Blind Trial of Abatacept and Glucocorticoids for Treatment of Takayasu’s Arteritis
Vasculitis – Oral Session I: Novel Approaches to Therapy
Carol A. Langford, MD, MHS (full author list)
2:30-4:00 p.m.
Sunday, Nov. 13
The Relationship between Systemic Sclerosis and Breast Cancer and the Effects on Treatment Outcome
Session title: Systemic Sclerosis, Fibrosing Syndromes, and Raynaud’s – Clinical Aspects and Therapeutics – Poster Session I
Pichaya O-Charoen, MD, Soumya Chatterjee, MD, MS (full author list)
Presentation time: 9-11 a.m.
Monday, Nov. 14
Rheumatic Immune Related Adverse Events of Checkpoint Therapy for Cancer: Case Series of a New Nosologic Entity
Session title: Miscellaneous Rheumatic and Inflammatory Diseases – Poster Session II
Cassandra Calabrese, DO, Apostolos Kontzias, MD, Vamsidhar Velcheti, MD, Leonard H. Calabrese, DO
Presentation time: 9-11 a.m.
Selective Inhibition of Tumor Necrosis Factor-α Receptor 2 (TNFR2) Activity Alleviates Psoriasiform Inflammation in Mouse Models
Session title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology –Poster Session I
Unnikrishnan Chandrasekharan, PhD, Zeneng Wang, PhD, Paul DiCorleto, PhD, M. Elaine Husni, MD, MPH (full author list)
Presentation time: 9-11 a.m.
Tuesday, Nov. 15
Differentiation between Neurosarcoidosis and Primary CNS Vasculitis Based on Clinical and Cerebrospinal Fluid Parameters
Session title: Vasculitis – Poster Session III: Rarer Vasculitides
Didem Saygin, MD, Leonard H. Calabrese, DO, Elisabeth Ray, MD, William Messner, Jinny Tavee, MD, Rula A Hajj-Ali, MD
Presentation time: 9-11 a.m.
Advertisement
Thresholds of Benefit-Risk Trade-Offs from the Patient Perspective for Treatment Decisions in Moderate-to-Severe Rheumatoid Arthritis
Session title: Rheumatoid Arthritis Clinical Aspects – Poster Session III: Treatment- Monitoring, Outcomes, Adverse Events
M. Elaine Husni, MD, MPH (full author list)
Presentation time: 9-11 a.m.
Comparison of Patient Outcomes in Primary Angiitis of the Central Nervous System and Reversible Cerebral Vasoconstriction Syndrome
Session title: Vasculitis – Poster Session III: Rarer Vasculitides
Elisabeth Ray, MD, Seby John, MD, Didem Saygin, MD, Ken Uchino, MD, Leonard H. Calabrese, DO, Rula A Hajj-Ali, MD
Presentation time: 9-11 a.m.
Patient Outcomes in Primary Angiitis of the Central Nervous System
Session title: Vasculitis – Poster Session III: Rarer Vasculitides
Elisabeth Ray, MD, Didem Saygin, MD, Anabelle Morales-Mena, MD, William Messner, Leonard H. Calabrese, DO, Rula A Hajj-Ali, MD
Presentation time: 9-11 a.m.
Advertisement
Advertisement
Older Psoriasis Patients May Experience Quicker Transition
Cleveland Clinic’s Rheumatic Lung Disease program treats patients with complex conditions
Some patients exhibit marked nodulosis due to undiagnosed tophi
A century-old medical tradition inspired the weekly complex-case reviews in Rheumatology
Multidisciplinary care may help clear barriers to treatment
Genetic polymorphisms and response to TNFα blockers
Patient’s 2-year symptom history leads to an uncommon diagnosis
Adam Brown, MD, shares his passion for solving rheumatologic mysteries